RAMPART: A model for a regulatory-ready academic-led phase III trial in the adjuvant renal cell carcinoma setting. (2021)
Attributed to:
Effective and efficient conduct of trials and meta-analyses
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.cct.2021.106481
PubMed Identifier: 34538401
Publication URI: http://europepmc.org/abstract/MED/34538401
Type: Journal Article/Review
Volume: 108
Parent Publication: Contemporary clinical trials
ISSN: 1551-7144